- Filed
- Aug 9, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2024 · Mar 31, 2023 | $432.7M |
| Long Term Debt | Q1 2024 · Jul 2, 2022 | $167.09M |
| Short Term Debt | Q1 2024 · Mar 31, 2023 | $10M |
| Short Term Debt | Q1 2024 · Jul 2, 2022 | $4M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $12.26M |
| Cash And Equivalents | Q1 2024 · Jul 2, 2022 | $12.24M |
| Current Liabilities | Q1 2024 · Mar 31, 2023 | $156.19M |
| Current Liabilities | Q1 2024 · Jul 2, 2022 | $215.95M |
| Total Liabilities | Q1 2024 · Mar 31, 2023 | $657.97M |
| Total Liabilities restated | Q1 2024 · Jul 2, 2022 | $459.2M |
| Current Assets | Q1 2024 · Mar 31, 2023 | $794.04M |
| Current Assets restated | Q1 2024 · Jul 2, 2022 | $629.1M |
| Total Assets | Q1 2024 · Mar 31, 2023 | $1.21B |
| Total Assets restated | Q1 2024 · Jul 2, 2022 | $1.03B |
| Shares Diluted | Q1 2024 · Jul 2, 2022 | 8.23K sh |
| Stock Repurchased | Q1 2024 · Jul 2, 2022 | $15.92M |
| Dividends Paid | Q1 2024 · Jul 2, 2022 | $12K |
| Capex | Q1 2024 · Jul 2, 2022 | $19.23M |
| Operating Cash Flow | Q1 2024 · Jul 2, 2022 | −$22.82M |
| Stockholders Equity restated | Q1 2024 · Jul 2, 2022 | $568.31M |
| Eps Diluted | Q1 2024 · Jul 2, 2022 | $0.62 |
| Eps Basic | Q1 2024 · Jul 2, 2022 | $0.62 |
| Sga Expense | Q1 2024 · Jul 2, 2022 | $18.24M |
| Net Income | Q1 2024 · Jul 2, 2022 | $5.1M |
| Operating Income | Q1 2024 · Jul 2, 2022 | $6.6M |
| Cost Of Revenue | Q1 2024 · Jul 2, 2022 | $242.35M |